Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
04 Febbraio 2025 - 10:05PM
Edgar (US Regulatory)
 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a)
of
the Securities Exchange Act of 1934 (Amendment No.   )
Filed by the Registrant x
Filed by a Party other than the Registrant ¨
Check the appropriate box:
| ¨ | Preliminary Proxy Statement |
| ¨ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ¨ | Definitive Proxy Statement |
| x | Definitive Additional Materials |
| ¨ | Soliciting Material under §240.14a-12 |
Marker Therapeutics, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other
than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| ¨ | Fee paid previously with preliminary materials. |
| ¨ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
| Get informed before you vote
*If you choose to vote these shares in person at the meeting, you must request a “legal proxy.” To do so, please follow the instructions at www.ProxyVote.com or request a
paper copy of the materials, which will contain the appropriate instructions. Please check the meeting materials for any special requirements for meeting attendance.
Smartphone users
Point your camera here and
vote without entering a
control number
Your Vote Counts!
FLASHID-JOB#
For complete information and to vote, visit www.ProxyVote.com
Control #
Ricky Campana
P.O. Box 123456
Suite 500
51 Mercedes Way
Edgewood, NY 11717
148,294
322,224
1 OF 2
30#
Hextone, Inc.
P.O. Box 9142
Farmingdale, NY 11735
XXXX XXXX XXXX XXXX
MARKER THERAPEUTICS, INC.
2025 Special Meeting
Vote by March 20, 2025
11:59 PM ET
You invested in MARKER THERAPEUTICS, INC. and it's time to vote!
You have the right to vote on proposals being presented at the Special Meeting. This is an important notice regarding the
availability of proxy material for the shareholder meeting to be held on March 21, 2025.
View the Proxy Statement online OR you can receive a free paper or email copy of the material(s) by requesting prior to March 09,
2025. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit
www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include
your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.
Vote in Person at the Meeting*
March 21, 2025
9:00 AM CDT
Annual Meeting to be held virtually
To attend, you must register as a
Beneficial Holder at the below URL:
https://web.viewproxy.com/markertherapeutics/2025SM |
| Voting Items
Board
Recommends
THIS IS NOT A VOTABLE BALLOT
This is an overview of the proposals being presented at the
upcoming shareholder meeting. Please follow the instructions on
the reverse side to vote these important matters.
Vote at www.ProxyVote.com
FLASHID-JOB#
Control # XXXX XXXX XXXX XXXX
1.00000
322,224
148,294
Under New York Stock Exchange rules, brokers may vote “routine” matters at their discretion if your voting instructions are not communicated
to us at least 10 days before the meeting. We will nevertheless follow your instructions, even if the broker’s discretionary vote has
already been given, provided your instructions are received prior to the meeting date.
MARKER THERAPEUTICS, INC.
2025 Special Meeting
Vote by March 20, 2025
11:59 PM ET
1 To approve, in accordance with Nasdaq Listing Rule 5635(d), the issuance of the shares issuable upon exercise of (i)
Private Placement Warrants to acquire 5,031,250 shares of Common Stock and (ii) Pre-Funded Warrants to acquire
3,247,445 additional shares of Common Stock.
For
NOTE: Such other business as may properly come before the meeting or any adjournment thereof. |
Grafico Azioni Marker Therapeutics (NASDAQ:MRKR)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni Marker Therapeutics (NASDAQ:MRKR)
Storico
Da Feb 2024 a Feb 2025